This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Choi, D. H. Articles by Haffty, B. G. Search for Related Content PubMed PubMed Citation Articles by Choi, D. H. Articles by Haffty, B. G. Social Bookmarking                            What's this?

Incidence of BRCA1 and BRCA2 Mutations in Young Korean Breast Cancer Patients

From the Departments of Therapeutic Radiology, Genetics, and Pathology, Yale University School of Medicine, New Haven, CT; and the Department of Surgery, Soonchunhyang University, Seoul, Korea.

Address reprint requests to Bruce G. Haffty, MD, Department of Therapeutic Radiology, Yale University School of Medicine, 333 Cedar St, New Haven, CT 06520-8040; e-mail: bruce.haffty{at}yale.edu

PURPOSE: The prevalence of BRCA-associated breast carcinoma in the Korean population has not been evaluated extensively.

METHODS: Sixty Korean women who developed breast cancer by age 40 years were studied. Lymphocyte specimens from peripheral blood were processed for BRCA1 and BRCA2 by complete sequencing. Family history through three generations was obtained. Available paraffin-embedded tissue blocks were processed for immunohistochemical staining.

RESULTS: In the cohort of 60 patients, nine patients with 11 deleterious mutations (six in BRCA1 and five in BRCA2) and seven missense mutations of unknown significance were found. Two patients had deleterious mutations in both BRCA1 and BRCA2 (double mutant). One half of the mutations were novel, and no founder mutations were observed in this cohort. Most of the BRCA-associated patients had no family history of breast and/or ovarian cancer. The expression of HER-2/neu, cyclin D1, and hormone receptors was less common, and p53 overexpression was more common in BRCA-associated tumors.

CONCLUSION: The prevalence of BRCA1 and BRCA2 mutations in Korean women with breast cancer at a young age was high. However, the penetrance, as evidenced by the low frequency of breast and ovarian cancers in family members, appears to be low. These data suggest that there may be different genetic and etiologic factors affecting transmission and penetrance of the BRCA genes in Korean patients with breast cancer diagnosed at a young age.

Supported by Greenwich Breast Cancer Alliance and the Ethel F. Donaghue Women's Health Investigator Program at Yale University School of Medicine.

Authors' disclosures of potential conflicts of interest are found at the end of this article.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				B. G. Haffty, D. H. Choi, S. Goyal, A. Silber, K. Ranieri, E. Matloff, M. H. Lee, M. Nissenblatt, D. Toppmeyer, and M. S. Moran Breast cancer in young women (YBC): prevalence of BRCA1/2 mutations and risk of secondary malignancies across diverse racial groups Ann. Onc., June 2, 2009; (2009) mdp051v1. [Abstract] [Full Text] [PDF]

				J. K. Kim, B. S. Kwak, J. S. Lee, S. J. Hong, H. J. Kim, B. H. Son, and S. H. Ahn Do Very Young Korean Breast Cancer Patients Have Worse Outcomes? Ann. Surg. Oncol., December 1, 2007; 14(12): 3385 - 3391. [Abstract] [Full Text] [PDF]

				P. Ang, I. H.K. Lim, T.-C. Lee, J.-T. Luo, D. C.T. Ong, P. H. Tan, and A. S.G. Lee BRCA1 and BRCA2 Mutations in an Asian Clinic-based Population Detected Using a Comprehensive Strategy Cancer Epidemiol. Biomarkers Prev., November 1, 2007; 16(11): 2276 - 2284. [Abstract] [Full Text] [PDF]

				B Leegte, A H van der Hout, A M Deffenbaugh, M K Bakker, I M Mulder, A ten Berge, E P Leenders, J Wesseling, J de Hullu, N Hoogerbrugge, et al. Phenotypic expression of double heterozygosity for BRCA1 and BRCA2 germline mutations J. Med. Genet., March 1, 2005; 42(3): e20 - e20. [Full Text] [PDF]